Literature DB >> 15342279

Leptin inhibits norepinephrine efflux from the hypothalamus in vitro: role of gamma aminobutyric acid.

Joseph Francis1, Sheba M J MohanKumar, P S MohanKumar.   

Abstract

Leptin, a hormone secreted by adipocytes, produces a number of central and neuroendocrine effects, the mechanisms behind which are not completely understood. Hypothalamic norepinephrine (NE) is involved in many of the neuroendocrine effects that are associated with leptin. Therefore, we hypothesized that leptin could affect hypothalamic NE activity to bring about its central and neuroendocrine effects. Because gamma aminobutyric acid (GABA) is known to affect the release of NE, we also tested the possibility that leptin-induced changes in NE could be mediated through GABA. The mediobasal hypothalami from adult male rats were incubated in an in vitro incubation system for four consecutive incubation periods of 60 min each at 37 degrees C in Krebs Ringers Henseleit (KRH) solution in an atmosphere of 95% O(2) and 5% CO(2.) After determining the basal release, the hypothalami were challenged with 0, 0.1, 1 or 10 nm of leptin, bicuculline (a GABA-A receptor antagonist; 10 microM) and bicuculline (10 microM) +10 nM of leptin during the second incubation period. Residual effects of leptin were measured in the third incubation where tissues were incubated with KRH alone, and the viability of tissues was determined in the fourth incubation when tissues were exposed to high K(+) KRH. NE levels in the incubation medium were measured using high-performance liquid chromatography with electrochemical detection (HPLC-EC). Leptin inhibited NE efflux from the hypothalamus in a dose-dependent manner. Moreover, incubation of hypothalami with 10 nM of leptin and bicuculline, a completely blocked the leptin-induced decrease in NE efflux. These results demonstrate for the first time that leptin could act directly on the hypothalamus to inhibit NE efflux through GABA. It was concluded that leptin could probably produce its central and neuroendocrine effects by modulating NE and GABA levels in the hypothalamus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342279     DOI: 10.1016/j.brainres.2004.07.010

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Developmental programming of cardiovascular disorders: focus on hypertension.

Authors:  Sheba M J MohanKumar; Andrew King; Andrew C Shin; Madhu P Sirivelu; P S MohanKumar; Gregory D Fink
Journal:  Rev Endocr Metab Disord       Date:  2007-08-01       Impact factor: 6.514

2.  Systemic administration of leptin decreases plasma corticosterone levels: role of hypothalamic norepinephrine.

Authors:  Kimberly A Clark; Andew C Shin; Madhu P Sirivelu; Sheba M J Mohankumar; P S Mohankumar
Journal:  Brain Res       Date:  2007-12-14       Impact factor: 3.252

3.  Chronic estradiol-17β exposure suppresses hypothalamic norepinephrine release and the steroid-induced luteinizing hormone surge: role of nitration of tyrosine hydroxylase.

Authors:  Badrinarayanan S Kasturi; Sheba M J MohanKumar; Madhu P Sirivelu; Andrew C Shin; P S Mohankumar
Journal:  Brain Res       Date:  2012-11-26       Impact factor: 3.252

4.  Antagonistic modulation of NPY/AgRP and POMC neurons in the arcuate nucleus by noradrenalin.

Authors:  Lars Paeger; Ismene Karakasilioti; Janine Altmüller; Peter Frommolt; Jens Brüning; Peter Kloppenburg
Journal:  Elife       Date:  2017-06-20       Impact factor: 8.140

5.  Responsiveness of hypothalamo-pituitary-adrenal axis to leptin is impaired in diet-induced obese rats.

Authors:  Andrew C Shin; Sheba M J MohanKumar; Priya Balasubramanian; Madhu P Sirivelu; Katrina Linning; Andrew Woolcock; Michelle James; Puliyur S MohanKumar
Journal:  Nutr Diabetes       Date:  2019-03-18       Impact factor: 5.097

Review 6.  Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.

Authors:  Torsten Lowin; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2015-09-06       Impact factor: 5.156

7.  Metformin effectively restores the HPA axis function in diet-induced obese rats.

Authors:  Andrew C Shin; Priya Balasubramanian; Pavan Suryadevara; Justin Zyskowski; Thomas H Herdt; Sheba M J MohanKumar; Puliyur S MohanKumar
Journal:  Int J Obes (Lond)       Date:  2020-09-19       Impact factor: 5.095

8.  Evaluation of the Central Effects of Systemic Lentiviral-Mediated Leptin Delivery in Streptozotocin-Induced Diabetic Rats.

Authors:  Kimberly A Clark; Andrew C Shin; Madhu P Sirivelu; Ramya C MohanKumar; Sreenivasa R Maddineni; Ramesh Ramachandran; Puliyur S MohanKumar; Sheba M J MohanKumar
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.